Study of CBME in the Relief of Painful Diabetic Neuropathy
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The study is designed to investigate the benefit of adding CBME to the existing treatment
regime in the management of painful neuropathy.
Hypothesis:
1. The addition of CBME to the existing treatment regime will result in a significant
improvement in both primary and secondary outcome measures.
2. The side effect profile and tolerability of CBME will be minimal and comparable to
placebo.